Sequoia Capital Israel

Cloudphysician is a prominent provider of Smart-ICU services that utilizes a cloud-based platform to enhance critical care delivery. The company employs advanced technologies, including artificial intelligence, the Internet of Things, and predictive analytics, to facilitate real-time clinical decision-making and improve patient outcomes. By offering remote management solutions, Cloudphysician enables healthcare providers to monitor patients effectively, assisting in early-stage diagnosis of critical illnesses in adults and tracking the health and immunization of newborns to reduce neonatal mortality rates. Through this innovative approach, Cloudphysician aims to transform the healthcare landscape, providing hospitals and healthcare professionals with improved support and training capabilities.

Taiyi Guanjia is a company that combines technology and medical health innovation, aiming to enhance the insurance industry and create a robust medical and health ecosystem.

Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.

Neurowyzr is a company focused on enhancing brain health through a comprehensive healthcare platform. It specializes in the detection, diagnosis, therapy, monitoring, and prevention of brain decline. By offering a range of evidence-based tools, Neurowyzr empowers healthcare providers to promote awareness and facilitate positive changes in brain health. The company's approach emphasizes early intervention and the prevention of cognitive decline, aiming to shift societal perspectives on brain health and encourage proactive maintenance of cognitive well-being.

Noah Medical is a manufacturer of medical robotic devices specialized in the diagnosis and treatment of patients across various medical conditions. The company's innovative devices facilitate early diagnoses and treatments within advanced clinical environments, empowering hospitals to address health issues promptly. This capability not only enhances patient outcomes but also contributes to reduced scarring, thereby improving the overall quality of care.

HealiRNA develops infectious disease vaccines, tumor vaccines, cell therapy, and protein replacement. They provide mRNA drug research and development, production, clinical trial design, and data analysis services.

Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

Founded in 2012, Vivolight is a medical device company incubated and supported by Xi'an Institute of Optics and Precision Mechanics of Chinese Academy of Sciences. We are headquartered in Shenzhen and have established an R&D center in Xi’an. Rooted in the field of medical laser technology, we are committed to the independent development, global innovation and independent manufacturing of medical devices used for minimally invasive interventional diagnosis and treatment with the technology of laser by leveraging the world-leading photoelectric technology and combining medicine and engineering. In April 2020, our self-developed optical coherence tomography (OCT) system obtained the approval of NMPA and achieved commercialization. In December 2021, our innovative Multimodality OCT System was approved by NMPA. It is the first Multimodality OCT System in the field of coronary artery OCT that has been approved for clinical application. In the field of interventional laser therapy, we have multiple products that have entered the phase of pre-clinical study.

Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Us2.ai specializes in developing artificial intelligence-driven software and digital tools for echocardiography. Based in Singapore, it offers online solutions to simplify access to echo analysis results and heart ultrasound.

Sirka is Indonesia's first metabolic clinic, specializing in healthcare innovation with a focus on obesity and metabolic health. The company adopts a tech-enabled, holistic approach to managing weight and chronic diseases, addressing the root causes of these issues. Sirka offers personalized programs that encompass weight management, digestive health, diabetes care, and chronic disease management. Through expert medical care and customized nutrition plans, the clinic tailors its services to meet individual needs while providing continuous monitoring to ensure effective support for long-term success. Additionally, Sirka's application connects users with dietitians for meal plan recommendations, facilitating goal setting related to diet and health conditions. This comprehensive approach empowers Indonesians to lead healthier lives with improved weight management and better control over chronic diseases.

the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.

Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic (IVD) company based in Suzhou, China, with a research and development office in Singapore. Founded in 2019, the company specializes in developing advanced diagnostic platforms for the detection of infectious diseases, cancer, and chronic diseases. Its technology offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Virtue Diagnostics aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

Vico Medical, established in 2018 and based in Wuhan, China, specializes in the development and production of medical devices aimed at treating cardiovascular and cerebrovascular diseases. The company offers a range of products, including atrial shunts, puncture systems, and occluders for patent foramen ovale, along with delivery systems and other related devices. Vico Medical focuses on providing innovative intervention treatment solutions for structural cardiovascular issues, contributing to the reduction of stroke and heart-related disease incidents.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Mosaic Wellness is a platform of digital-first health clinics and wellness brands operating in India under a single umbrella. It provides medical consultations, personalized wellness assessments, and a range of wellness products through its digital platform, with specialized offerings for men's and women's health. By linking multiple digital health brands, Mosaic Wellness seeks to help individuals lead healthier, more fulfilling lives through accessible, tailored care and products.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Metware is a developer of advanced medical metabolic technology, focusing on metabolomics to enhance life science research and clinical applications. The company specializes in metabolism analysis and testing services, targeting areas such as cancer, metabolic disorders, and infectious diseases. By leveraging innovative metabolism technology, Metware aims to provide effective data analysis that supports patients and facilitates improved treatment options in the medical field.

Yixue Jie is an app that offers medical information to medical workers. They provide information in these categories such as grassroots medical voice in the medical field, medical tumor channel, medical rheumatology and immunity channel, medical skin channel, medical cardiovascular channel, medical endocrinology channel, medical neurology channel, medical blood channel, medical pediatric channel, medical obstetrics and gynecology channel, medical respiratory channel, medical nephrology channel, digestive liver disease channel in medical circles, clinical pharmacy channel of the medical community, medical rare disease channel, medical cancer association, medical emergency and critical care channel, medical spirit channel, medical surgical channel, medical nursing channel, medical ophthalmology channel, medical infection channel, medical anesthesia channel, medical orthopedics channel, medical testing channel, medical image diagnosis and intervention channel, medical pathology channel, clinical decision assistant, a course in the medical field, and medical examination. It helps clinicians in clinical decision-making and professional advancement.

Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Analytical Biosciences is a developer of single-cell genomics focused on creating precise maps of human diseases. The company collaborates with medical research institutions, hospitals, and pharmaceutical firms to leverage single-cell genomics and bioinformatics for improving disease diagnosis and treatment. By conducting large-scale systematic mapping of diseases at the single-cell level, Analytical Biosciences engages in extensive data mining to support its partners in discovering new therapeutic targets and developing innovative treatment strategies. Utilizing high-resolution databases and advanced data analytics, the company aims to unlock disease mechanisms and facilitate the identification and validation of novel cellular targets and biomarkers. This approach positions Analytical Biosciences at the forefront of advancing next-generation therapeutics and diagnostics.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

Jianhai Technology is an AI whole-course management platform that provides users with post-hospital & post-diagnosis management services.

Neuracle is a prominent enterprise in China's neuroscience sector, specializing in neural monitoring and diagnostic technology. Leveraging advanced brain-machine interface technology developed through collaboration with Tsinghua University, Neuracle focuses on innovative research in neuroscience, psychology, and neuroengineering. The company provides comprehensive solutions for the diagnosis, treatment, and rehabilitation of clinical neurological diseases. Its product offerings include digital electroencephalographs and other tools that allow healthcare institutions to monitor patients' brain bioelectricity levels and accurately diagnose neural conditions. Neuracle's research and development efforts have garnered acceptance from experts in both neuroscience and clinical medicine, positioning the company as a leader in its field and a key contributor to national science and technology initiatives.

ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.

Virta Health is a San Francisco–based health technology company that specializes in treating type 2 diabetes through an online, physician-supported program. The company combines nutritional biochemistry, data science, and digital tools to deliver on-demand care via a continuous remote care platform, providing physicians and health coaches who guide patients to reduce blood sugar and lose weight without medications or surgery. Founded in 2014, Virta offers a treatment approach aimed at reversing type 2 diabetes and improving related metabolic and cardiovascular health.

Genki Forest is a beverage company that focuses on producing sugar-free and low-calorie drinks, catering to consumers seeking healthy and flavorful options. The company specializes in manufacturing a range of beverages, including sugar-free tea and flavored seltzer water, created from natural ingredients. Genki Forest aims to provide affordable, health-conscious beverages, aligning with the growing demand for nutritious drink alternatives in the market.

SiBionics is a medtech company headquartered in Shenzhen, China, focused on the research, development, and commercialization of active implantable medical devices and medical artificial intelligence. The company specializes in innovative solutions for medical imaging and neuromodulation, striving to create cost-effective products that enhance long-term health monitoring and disease management. SiBionics is developing various advanced technologies, including implanted retinal electrical stimulators, continuous glucose monitoring systems, and screening tools for gastric cancer and chronic diseases. Through the integration of visual coding, artificial intelligence, and medical big data, SiBionics aims to address critical health issues such as retinitis pigmentosa, diabetes, cardiovascular and cerebrovascular diseases, and gastrointestinal tumors, ultimately improving diagnostic and treatment options for these conditions.

Qure.ai Technologies Private Limited specializes in developing artificial intelligence software for the healthcare sector, focusing on medical imaging to enhance disease diagnosis from radiology and pathology images. Founded in 2016 and headquartered in Mumbai, India, with a presence in New York, the company offers tools such as qXR, which automates chest X-ray interpretation to identify abnormal findings, including signs of tuberculosis. Qure.ai also provides qER, which assists in triaging critical head CT scans and offers tools for monitoring traumatic brain injury and reporting. By leveraging deep learning solutions, Qure.ai aims to improve the accuracy of diagnoses and make healthcare more affordable and accessible, ultimately allowing healthcare professionals to dedicate more time to patient care.

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Eko.ai Pte. Ltd. is a Singapore-based company that specializes in developing artificial intelligence software for the early detection and treatment of heart disease. Founded in 2017, the company focuses on democratizing echocardiography and ultrasound technology to identify cardiovascular risks more effectively. Eko.ai collaborates with clinician scientists, sonographers, and deep learning experts to create automated tools that enhance the capabilities of research teams in the field of cardiac imaging. Its software provides fully classified, machine learning-ready research databases, along with a suite of models, segmentation tools, and validation cohorts. By equipping hospital systems with these productivity tools, Eko.ai aims to improve health outcomes for patient populations while advancing the fight against heart disease.

Fussen Technology, established in 2012 and headquartered in Shenzhen, China, specializes in the development of digital dental imaging equipment. The company focuses on creating comprehensive solutions for the dental healthcare sector, including Cone Beam Computed Tomography (CBCT), Intraoral Scanners (IOS), Imaging Plate Scanners, and a SaaS-based clinic management system. Additionally, Fussen Technology has developed a digital intelligence platform, Dental X-Dental, to streamline dental healthcare services.

RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.

BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.

Mosaic Wellness is a platform of digital-first health clinics and wellness brands operating in India under a single umbrella. It provides medical consultations, personalized wellness assessments, and a range of wellness products through its digital platform, with specialized offerings for men's and women's health. By linking multiple digital health brands, Mosaic Wellness seeks to help individuals lead healthier, more fulfilling lives through accessible, tailored care and products.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

Burning Rock Biotech is a cancer diagnostics company that leverages next-generation sequencing and bioinformatics to guide personalized cancer treatment. It develops and provides a portfolio of tissue- and blood-based, NGS-driven therapy selection tests, including OncoScreen Plus, LungPlasma, ColonCore and HRDCore, and evaluates biomarkers such as microsatellite instability, tumor mutation burden, and NTRK fusions across multiple cancer types, including lung, gastrointestinal, prostate, breast, hematologic, thyroid, colorectal, ovarian, pancreatic, and bladder cancers. The company supports clinical and research use through one-stop services spanning genetic testing and companion diagnostic development, operating through central laboratory and in-hospital models. It collaborates with major pharmaceutical companies on clinical trials and research to advance targeted therapies and diagnostics. Founded in 2014, it is headquartered in Guangzhou, with a Guangzhou laboratory and an R&D center in Shanghai, reflecting its focus on expanding access to precision oncology in China.

Medtrum Technologies Inc., established in 2008, specializes in developing and delivering medical devices for diabetes management. Its product portfolio includes the A6 TouchCare System, a tubing-free, semi-closed loop insulin management system that integrates an insulin patch pump and continuous glucose monitoring (CGM) with predictive low glucose suspend features. The S6 EasySense is a waterproof, disposable CGM system providing real-time glucose readings for a week. The P6 EasyPatch is a disposable insulin pump offering adjustable basal rates and bolus on demand. Medtrum's cloud-based healthcare system, comprising the EasyTouch mobile app and EasyView web portal, consolidates patient data for self-management, family support, and healthcare provider access. With headquarters in Shanghai, China, Medtrum also operates in Düsseldorf, Germany; Hong Kong; and Watford, UK.

VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.

Synyi is a provider of AI-powered healthcare data platforms for medical institutions and regulatory agencies, specializing in medical big data management systems, intelligent diagnostic tools, digital healthcare applications, and EEG-based case generation models that support clinical research, enhance operational efficiency, and enable digital transformation across the healthcare ecosystem. The company benefits from a highly qualified core team drawn from leading universities and international organizations in artificial intelligence, medicine, and medical informatics, whose technical achievements have been applied to national and municipal projects and who have published extensively in international journals and spoken at major medical conferences.

NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

MedGenome develops sequencing-based diagnostics and a research platform that combines genomics technologies, bioinformatics, computing, and big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases in diverse populations. The platform enables high-end genetic diagnostic tests across immuno-oncology, infectious diseases, reproductive health, and rare diseases, and serves patients, pharmaceutical companies, and research institutions worldwide by delivering deep insights into diseases at the genetic and molecular level to advance global health.

Synyi is a provider of AI-powered healthcare data platforms for medical institutions and regulatory agencies, specializing in medical big data management systems, intelligent diagnostic tools, digital healthcare applications, and EEG-based case generation models that support clinical research, enhance operational efficiency, and enable digital transformation across the healthcare ecosystem. The company benefits from a highly qualified core team drawn from leading universities and international organizations in artificial intelligence, medicine, and medical informatics, whose technical achievements have been applied to national and municipal projects and who have published extensively in international journals and spoken at major medical conferences.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services. Founded in 1999, The Hong Kong Asian Heart Center has a professional medical team with many years of experience in the treatment of heart disease.

Suburban Diagnostics is a provider of comprehensive diagnostic and pathology services, operating multiple centers across Maharashtra. The company specializes in delivering precise diagnostics and accurate reporting, with a focus on pathology, radiology, and cardiology. In addition to its diagnostic services, Suburban Diagnostics offers health check-up programs, aiming to enhance the quality of care for patients and support healthcare providers in their treatment efforts. Through its commitment to accuracy and comprehensive service offerings, Suburban Diagnostics plays a crucial role in the healthcare landscape.

Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Burning Rock Biotech is a cancer diagnostics company that leverages next-generation sequencing and bioinformatics to guide personalized cancer treatment. It develops and provides a portfolio of tissue- and blood-based, NGS-driven therapy selection tests, including OncoScreen Plus, LungPlasma, ColonCore and HRDCore, and evaluates biomarkers such as microsatellite instability, tumor mutation burden, and NTRK fusions across multiple cancer types, including lung, gastrointestinal, prostate, breast, hematologic, thyroid, colorectal, ovarian, pancreatic, and bladder cancers. The company supports clinical and research use through one-stop services spanning genetic testing and companion diagnostic development, operating through central laboratory and in-hospital models. It collaborates with major pharmaceutical companies on clinical trials and research to advance targeted therapies and diagnostics. Founded in 2014, it is headquartered in Guangzhou, with a Guangzhou laboratory and an R&D center in Shanghai, reflecting its focus on expanding access to precision oncology in China.

Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.

Health 724 is a health service provider based on users, health managers, and health products. They offer direct supply of health products to users who are concerned about their own and their families' health, as well as customized health solutions.

Life Infinity is a health management company dedicated to providing personalized health services aimed at age-specific diagnosis, treatment, and disease prevention. The company focuses on systematic management of chronic diseases, delaying the effects of aging, and relieving symptoms associated with various health conditions. Additionally, Life Infinity offers specialized services in health regeneration, anti-aging medical treatments, and natural healing programs, enabling clients to access professional regenerative medicine services tailored to individual needs.

Founded in 2015, Orasis Pharmaceuticals specializes in developing corrective eye drops for treating presbyopia. Its lead product, CSF-1, improves near visual acuity by pupil modulation, eliminating the need for reading glasses.

Life Infinity is a health management company dedicated to providing personalized health services aimed at age-specific diagnosis, treatment, and disease prevention. The company focuses on systematic management of chronic diseases, delaying the effects of aging, and relieving symptoms associated with various health conditions. Additionally, Life Infinity offers specialized services in health regeneration, anti-aging medical treatments, and natural healing programs, enabling clients to access professional regenerative medicine services tailored to individual needs.

Dongri Zhongyi Guan is a chain organisation for TCM diagnosis and treatment that integrates Internet technologies with the fundamental principles of traditional TCM. Pediatric illnesses, andrological illnesses such as impotence, early ejaculation, prostate, etc., spleen and stomach illnesses, colds and flu, neck and lumbar illnesses, liver and gallbladder illnesses, and other illnesses are all treated by them.

Burning Rock Biotech is a cancer diagnostics company that leverages next-generation sequencing and bioinformatics to guide personalized cancer treatment. It develops and provides a portfolio of tissue- and blood-based, NGS-driven therapy selection tests, including OncoScreen Plus, LungPlasma, ColonCore and HRDCore, and evaluates biomarkers such as microsatellite instability, tumor mutation burden, and NTRK fusions across multiple cancer types, including lung, gastrointestinal, prostate, breast, hematologic, thyroid, colorectal, ovarian, pancreatic, and bladder cancers. The company supports clinical and research use through one-stop services spanning genetic testing and companion diagnostic development, operating through central laboratory and in-hospital models. It collaborates with major pharmaceutical companies on clinical trials and research to advance targeted therapies and diagnostics. Founded in 2014, it is headquartered in Guangzhou, with a Guangzhou laboratory and an R&D center in Shanghai, reflecting its focus on expanding access to precision oncology in China.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

MedGenome develops sequencing-based diagnostics and a research platform that combines genomics technologies, bioinformatics, computing, and big data analytics to understand the genetic basis of cancer, metabolic disorders, eye disorders, and other rare diseases in diverse populations. The platform enables high-end genetic diagnostic tests across immuno-oncology, infectious diseases, reproductive health, and rare diseases, and serves patients, pharmaceutical companies, and research institutions worldwide by delivering deep insights into diseases at the genetic and molecular level to advance global health.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Whale Imaging Inc., established in 1998, is a Massachusetts-based manufacturer of medical devices specializing in surgical imaging systems and ultrasound equipment. The company's product portfolio includes G-Arm Products like the G-Arm B6 Duo and G-Arm GXi 2, as well as portable ultrasound systems such as the Lambda P9 and Sigma P5. In addition to manufacturing, Whale Imaging offers training services, preventative maintenance, and customer support for its products. The company's headquarters are in Waltham, Massachusetts, with research and development facilities located in Boston.

Huami is a leading wearable device company known for the Amazfit line of fashion-forward activity trackers and smartwatches, including models such as Pace, Arc, Cor, Bip, Moonbeam and Equator. Launched in 2014, it has reported selling over 50 million devices and positions itself as the top wearable device company by units sold. The company focuses on integrating biomechanical signals and daily activities with smart data services to promote healthy living and simplify daily life. It is the exclusive wearable technology provider for Xiaomi and the maker of the Mi Band. Huami maintains operations in Beijing and Mountain View, California, supported by investors such as Sequoia Capital, Shunwei Capital Partners, Banyan Capital, Morningside Ventures and Xiaomi.

Tencent Trusted Doctors, a company established in early August 2018 upon the merger of Tencent Doctorwork and Trusted Doctors, is acquiring the start-up in an attempt to create a private healthcare network that provides both online and offline services through the so-called "celebrity effect".

Dayima Little Helper is a mobile application focused on providing menstrual period nursing help for women. In addition to the basic calendar function, Dayima also offers tailored and targeted tips to help users obtain the conditioning plan through the professional test. Dayima also has many interaction functions like forum, voting, and more.

Whale is a manufacturer of imaging devices, including multi-planar surgical imaging and portable diagnostic ultrasound products. It develops portable ultrasound systems and surgical imaging equipment, employing proprietary technologies and advanced manufacturing methods to produce safe devices that enable surgeons to perform procedures with speed and ease.

In China, almost every doctor must face overloaded with work. The number of patients they received a day or even a week,the number of foreign doctors will be reception. In addition to China's large population of natural conditions, the unity of the health care system, pattern, so difficult and tense doctor-patient relationship and other issues remain unresolved.

Dayima Little Helper is a mobile application focused on providing menstrual period nursing help for women. In addition to the basic calendar function, Dayima also offers tailored and targeted tips to help users obtain the conditioning plan through the professional test. Dayima also has many interaction functions like forum, voting, and more.

EndoChoice is a medical device company specializing in the development and commercialization of technologies for gastrointestinal (GI) care. Founded in 2008 and headquartered in Alpharetta, Georgia, the company offers a range of products that include single-use devices, diagnostics, infection control products, and endoscopic imaging systems tailored for GI specialists. One of its notable innovations is the Full Spectrum Endoscopy™ System, which features colonoscopes and gastroscopes equipped with multiple imagers, allowing for a wider field of view compared to traditional endoscopes. This technology has demonstrated its efficacy by detecting significantly more polyps during colonoscopy procedures. EndoChoice serves over 2,000 customers in the United States and collaborates with 34 distribution partners globally. The company was recognized by Inc. Magazine as one of the fastest-growing companies in the U.S. for four consecutive years prior to its acquisition by Boston Scientific in 2016.

Suburban Diagnostics is a provider of comprehensive diagnostic and pathology services, operating multiple centers across Maharashtra. The company specializes in delivering precise diagnostics and accurate reporting, with a focus on pathology, radiology, and cardiology. In addition to its diagnostic services, Suburban Diagnostics offers health check-up programs, aiming to enhance the quality of care for patients and support healthcare providers in their treatment efforts. Through its commitment to accuracy and comprehensive service offerings, Suburban Diagnostics plays a crucial role in the healthcare landscape.

BGI is a biotechnology company specializing in genomics. It provides genome sequencing and genetic testing services to research institutions and healthcare professionals worldwide. The company's offerings include bioinformatics, multi-omics solutions, and related tools, catering to a diverse range of clients such as pharmaceutical companies and academic institutions. BGI's work has contributed significantly to genetic and genomic research, with notable collaborations including Eli Lilly and Company, Merck, Pfizer Inc., and the Bill & Melinda Gates Foundation.

Practo is an online healthcare platform that facilitates various medical services for individuals and families. It allows users to assess health issues, find suitable doctors, book diagnostic tests, obtain medicines, and store health records, all in one place. The platform also enables patients to consult with doctors online, streamlining the appointment scheduling process and eliminating the need for physical visits to clinics. In addition to serving patients, Practo offers healthcare providers a comprehensive tool to enhance their online presence and engage more effectively with patients, thereby fostering deeper connections within the healthcare community.

Hinacom Software and Technology, Ltd. is a Beijing-based healthcare IT company that specializes in medical imaging and information management solutions. Established in 2008, the company offers its flagship product, miPlatform, an integrated suite designed for the medical imaging industry. This suite encompasses various components, including Enterprise PACS/RIS for optimized workflow management, Regional PACS for collaborative imaging services across hospitals, and TeleMed/TeleRad systems for image transmission and conferencing via web platforms. Additionally, miPlatform features web-based 3D processing and mobile imaging systems. Hinacom’s solutions are utilized by hospitals and regional teleradiology projects in China, as well as by radiologists and clinicians across the United States, Europe, and Southeast Asia.

China Nuokang Bio-Pharmaceutical Inc. is a fully integrated, profitable bio-pharmaceutical company focused on researching, developing, manufacturing and marketing hematological and cardiovascular products. They sell a portfolio of fourteen products, which includes principal products Baquting®, a flagship hemocoagulase, and Aiduo®, a cardiovascular stress imaging agent. There product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention.

SAI Life Sciences is a global pharmaceutical services provider offering integrated solutions across drug discovery, development, and manufacturing for clients worldwide. Established in 1999, the company specializes in discovering, developing, and manufacturing medicines, with a focus on small molecule new chemical entities (NCEs). SAI operates through multiple facilities in India, Japan, the United States, and Europe, offering services such as synthetic chemistry, medicinal chemistry, biology, pharmacology, toxicology, and late-phase manufacturing. Its mission is to enable partners to develop innovative medicines more efficiently by providing reliable, high-quality scientific solutions.

ReaMetrix, Inc., established in 2003, is a biotechnology service provider headquartered in San Carlos, California, with an additional office in Bangalore, India. The company specializes in offering research and development services, including GMP-level assay development, validation, and testing to pharmaceutical, biotechnology, and diagnostic industries across the United States, India, and Japan. ReaMetrix provides labeled reagents and reagent kits for cell biology platforms, along with custom labeling and conjugation services tailored to clients' specifications.